in a double-blind , crossover study , 103 patients with parkinson 's disease and nocturnal and/or early-morning disabilities took a bedtime dose of either madopar cr ( controlled-release levodopa plus benserazide ) or standard madopar , in addition to their usual daytime levodopa regimen .
C0030567
parkinson 's disease
C0023570
levodopa